| pubmed-article:16804851 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16804851 | lifeskim:mentions | umls-concept:C0019351 | lld:lifeskim |
| pubmed-article:16804851 | lifeskim:mentions | umls-concept:C0019682 | lld:lifeskim |
| pubmed-article:16804851 | lifeskim:mentions | umls-concept:C0019699 | lld:lifeskim |
| pubmed-article:16804851 | lifeskim:mentions | umls-concept:C0021311 | lld:lifeskim |
| pubmed-article:16804851 | lifeskim:mentions | umls-concept:C0027361 | lld:lifeskim |
| pubmed-article:16804851 | lifeskim:mentions | umls-concept:C0001554 | lld:lifeskim |
| pubmed-article:16804851 | lifeskim:mentions | umls-concept:C0332307 | lld:lifeskim |
| pubmed-article:16804851 | lifeskim:mentions | umls-concept:C1273870 | lld:lifeskim |
| pubmed-article:16804851 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:16804851 | pubmed:dateCreated | 2006-6-28 | lld:pubmed |
| pubmed-article:16804851 | pubmed:abstractText | Human immunodeficiency virus type 1 (HIV-1)-infected persons have high rates of herpes simplex virus type 2 (HSV-2) infection, ranging from 50% to 90% in studies of HIV-infected populations from different parts of the world. Genital herpes in persons with HIV type 1 (HIV-1) infection is associated with more-severe and chronic lesions, as well as increased rates of asymptomatic genital shedding of HSV-2. Nucleoside analogues (acyclovir, valacyclovir, and famciclovir) decrease the frequency and severity of HSV-2 recurrences and asymptomatic HSV-2 reactivation and are effective, safe, well-tolerated drugs in patients with HIV-1 infection. These anti-HSV drugs may result in additional clinical and public health benefits for persons with HIV-1 and HSV-2 coinfection by decreasing HIV-1 levels in the blood and genital tract. Given these benefits, HIV-1-infected persons should be routinely tested for HSV-2 infection using type-specific serologic tests. Persons with HSV-2 infection should be offered HSV-2 education and treatment options. Studies to quantify the potential clinical and public health benefits of treating individuals who have HIV-1 and HSV-2 coinfection with anti-HSV therapy are underway. | lld:pubmed |
| pubmed-article:16804851 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16804851 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16804851 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16804851 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16804851 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16804851 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16804851 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16804851 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16804851 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:16804851 | pubmed:issn | 1537-6591 | lld:pubmed |
| pubmed-article:16804851 | pubmed:author | pubmed-author:WaldAnnaA | lld:pubmed |
| pubmed-article:16804851 | pubmed:author | pubmed-author:CelumConnieC | lld:pubmed |
| pubmed-article:16804851 | pubmed:author | pubmed-author:StrickLara... | lld:pubmed |
| pubmed-article:16804851 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:16804851 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:16804851 | pubmed:volume | 43 | lld:pubmed |
| pubmed-article:16804851 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16804851 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16804851 | pubmed:pagination | 347-56 | lld:pubmed |
| pubmed-article:16804851 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:16804851 | pubmed:meshHeading | pubmed-meshheading:16804851... | lld:pubmed |
| pubmed-article:16804851 | pubmed:meshHeading | pubmed-meshheading:16804851... | lld:pubmed |
| pubmed-article:16804851 | pubmed:meshHeading | pubmed-meshheading:16804851... | lld:pubmed |
| pubmed-article:16804851 | pubmed:meshHeading | pubmed-meshheading:16804851... | lld:pubmed |
| pubmed-article:16804851 | pubmed:meshHeading | pubmed-meshheading:16804851... | lld:pubmed |
| pubmed-article:16804851 | pubmed:meshHeading | pubmed-meshheading:16804851... | lld:pubmed |
| pubmed-article:16804851 | pubmed:meshHeading | pubmed-meshheading:16804851... | lld:pubmed |
| pubmed-article:16804851 | pubmed:meshHeading | pubmed-meshheading:16804851... | lld:pubmed |
| pubmed-article:16804851 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16804851 | pubmed:articleTitle | Management of herpes simplex virus type 2 infection in HIV type 1-infected persons. | lld:pubmed |
| pubmed-article:16804851 | pubmed:affiliation | Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA 98104, USA. strick@u.washington.edu | lld:pubmed |
| pubmed-article:16804851 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16804851 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:16804851 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16804851 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16804851 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16804851 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16804851 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16804851 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16804851 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16804851 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16804851 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16804851 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16804851 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16804851 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16804851 | lld:pubmed |
